PAN-301-1: HAAH Nanoparticle Therapeutic Vaccine for Cancer Treatment

Stage:  Clinical

 

PAN-622 RII:  Monochlonal Antibody Radio Immunoimaging Agent for Cancer Detection and Imaging

Stage:  Preclinical

 

PAN-622 RIT: Monochlonal Antibody Radio-Immunotherapy Agent for Cancer Treatment

Stage:  Preclinical

 

PAN-811 NP: Neuroprotection Agent for Chemotherapy-Induced Cognitive Impairment and Peripheral Neuropathy

Stage:  Preclinical

 

Cancer Test: HAAH-Based Immunoassay

Stage:  LDT (Laboratory Developed Test)